Bariatric Surgery vs Glucagon-Like Peptide-1 Analogues for Reducing Risk of Major Cardiovascular Events: A Multi-Center Retrospective Cohort Study

被引：0
|
作者：
Adekolu, Ayowumi A. [1 ]
Cohen, Ethan M. [1 ]
Maan, Soban A. [1 ]
Foryoung, Joyce [1 ]
Thakkar, Shyam A. [1 ]
Singh, Shailendra [1 ]
机构：
[1] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1282
引用
收藏
页码：S971 / S971
页数：1
相关论文
共 50 条
  • [1] Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality
    Dicker, Dror
    Sagy, Yael Wolff
    Ramot, Noga
    Battat, Erez
    Greenland, Philip
    Arbel, Ronen
    Lavie, Gil
    Reges, Orna
    JAMA NETWORK OPEN, 2024, 7 (06) : E2415392
  • [2] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [3] Comparison of Bariatric Surgery and Glucagon-Like Peptide-1 Analogs for Prevention of Nonalcoholic Fatty Liver Disease in an Obese Population: A Large Multi-Center Study
    Cohen, Ethan M.
    Adekolu, Ayowumi A.
    Maan, Soban A.
    Foryoung, Joyce
    Thakkar, Shyam
    Singh, Shailendra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1237 - S1237
  • [4] BARIATRIC SURGERY VERSUS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: A COMPARISON OF CARDIOVASCULAR OUTCOMES
    Maan, Soban
    Sohail, Amir H.
    Adekolu, Ayowumi A.
    Cohen, Ethan M.
    Thakkar, Shyam
    Singh, Shailendra
    GASTROENTEROLOGY, 2024, 166 (05) : S590 - S591
  • [5] Effects of glucagon-like peptide-1 on cardiovascular risk factors and cardiovascular system
    Fiorentino, Teresa Vanessa
    Sesti, Giorgio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2016, 17 (12) : 13S - 19S
  • [6] Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk
    Mannucci, E.
    Rotella, C. M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (09) : 639 - 645
  • [7] Association of glucagon-like peptide-1 receptor agonists with serious liver events: Scandinavian cohort study
    Engstrom, Arvid
    Wintzell, Victor
    Melbye, Mads
    Svanstrom, Henrik
    Eliasson, Bjorn
    Gudbjornsdottir, Soffia
    Hveem, Kristian
    Jonasson, Christian
    Hviid, Anders
    Pasternak, Bjorn
    Ueda, Peter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 8 - 9
  • [8] Effects of glucagon-like peptide-1 and long-acting analogues on cardiovascular and metabolic function
    Saraceni C.
    Broderick T.L.
    Drugs in R & D, 2007, 8 (3) : 145 - 153
  • [9] The Impact of Preoperative Glucagon-Like Peptide-1 Receptor Agonist Use on Bariatric Surgery Outcomes
    Abuhasan, Qais
    Li, Wendy
    Burney, Charles
    Funk, Luke M.
    Holl, Jane
    Selzer, Don
    Stefanidis, Dimitrios
    Yuce, Tarik
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S34 - S35
  • [10] RISK OF PANCREATIC CANCER IN PATIENTS TREATED WITH GLUCAGON LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: A LARGE MULTI-CENTER COHORT STUDY
    Singh, Shailendra
    Shah-Khan, Sardar M.
    Hadi, Yousaf
    Khan, Ahmad
    Sohail, Amir H.
    Daum, Tracy L.
    Humphries, Christine E.
    Chowdhry, Monica
    Malik, Adnan
    Sohail, Abdullah
    Ul Jannat, F. N. U. Rida
    Bilal, Mohammad
    Hutson, William R.
    Thakkar, Shyam
    GASTROENTEROLOGY, 2022, 162 (07) : S169 - S169
12345